構成的に活性であるロドプシンにおけるアゴニスト誘発活性化の構造的基礎
Jörg Standfuss1, Patricia C Edwards, Aaron D'Antona
1Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.
Nature
|March 11, 2011
まとめ
この研究は,Gタンパク質結合受容体 (GPCR) である視覚色素ロドプシンの活性構成を明らかにしています. この発見は,アゴニスト結合がGPCR活性化に必要な重要な形状の変化をどのように引き起こすかを明らかにしています.
科学分野:
- 構造生物学 構造生物学とは
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
背景:
- Gタンパク質結合受容体 (GPCR) は,細胞信号を媒介する重要な膜タンパク質である.
- 既存のGPCRの結晶構造は,主にアゴニストに結合した形状を欠いた不活性状態を表しています.
- ロドプシン構造は以前はオプシン形態に限定され,アゴニストオールトランス・レチナルは存在しなかった.
研究 の 目的:
- 活性ロドプシン構成の結晶構造を決定する.
- アゴニストによるGPCR活性化の分子メカニズムを解明する.
主な方法:
- 3 Å の解像度のX線結晶学.
- 構成的に活性なロドプシン変異体 (Glu 113 Gln) を研究した.
- トランスデューシンGタンパク質由来ペプチドによる複合形成.
主要な成果:
- 活性ロドプシンと光活性化後の網膜保持の結晶構造を提示しました.
- 主要な活性化イベントとして,網膜β-イオノンリングの転位とトランスメブランヘリックス6の回転を特定しました.
- 網膜結合ポケットにおける水媒介の水素結合の再編成が観察されました.
結論:
- この構造は,アゴニスト誘発のGPCR活性化モデルを提供する.
- 信号伝達における保存されたGPCRモチーフの役割を強調する.
- ロドプシン活性化を誘発する形状の変化を説明する.
関連する概念動画
Activation and Inactivation of G Proteins
8.9K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.9K
IP3/DAG Signaling Pathway
12.6K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.6K
Drug-Receptor Interaction: Agonist
4.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.4K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K


